As of 2024-12-15, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is 14.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 74.82 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is 5.12 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 12.3x | 10.7x |
| Forward P/E multiples | 7.0x - 11.2x | 9.0x |
| Fair Price | (1.98) - 0.50 | (0.65) |
| Upside | -222.5% - -69.3% | -140.0% |
| Date | EV/EBITDA |
| 2024-12-11 | 14.91 |
| 2024-12-10 | 14.85 |
| 2024-12-09 | 14.79 |
| 2024-12-06 | 14.56 |
| 2024-12-05 | 14.70 |
| 2024-12-04 | 14.81 |
| 2024-12-03 | 15.62 |
| 2024-12-02 | 16.61 |
| 2024-11-29 | 16.72 |
| 2024-11-28 | 16.68 |
| 2024-11-27 | 16.84 |
| 2024-11-26 | 17.02 |
| 2024-11-25 | 17.06 |
| 2024-11-22 | 17.04 |
| 2024-11-21 | 17.27 |
| 2024-11-20 | 17.14 |
| 2024-11-19 | 17.24 |
| 2024-11-18 | 17.19 |
| 2024-11-15 | 16.95 |
| 2024-11-14 | 16.91 |
| 2024-11-13 | 17.14 |
| 2024-11-12 | 17.27 |
| 2024-11-11 | 17.36 |
| 2024-11-08 | 17.02 |
| 2024-11-07 | 17.35 |
| 2024-11-06 | 17.30 |
| 2024-11-05 | 17.31 |
| 2024-11-04 | 17.51 |
| 2024-11-01 | 17.10 |
| 2024-10-31 | 16.99 |
| 2024-10-30 | 16.91 |
| 2024-10-29 | 17.60 |
| 2024-10-28 | 17.92 |
| 2024-10-25 | 17.99 |
| 2024-10-24 | 18.26 |
| 2024-10-23 | 18.13 |
| 2024-10-22 | 18.13 |
| 2024-10-21 | 18.36 |
| 2024-10-18 | 18.57 |
| 2024-10-17 | 20.27 |
| 2024-10-16 | 20.27 |
| 2024-10-15 | 20.57 |
| 2024-10-14 | 20.67 |
| 2024-10-11 | 20.89 |
| 2024-10-10 | 20.82 |
| 2024-10-09 | 20.86 |
| 2024-10-08 | 21.00 |
| 2024-10-07 | 20.95 |
| 2024-10-04 | 20.97 |
| 2024-10-03 | 20.98 |